Breaking News

List Labs Expands Manufacturing Capacity

Advances live biotherapeutics and biologics manufacturing capacity with 500L equipment.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

List Labs, a live biotherapeutics-focused contract development manufacturing organization (CDMO), has added 500L equipment to expand its bacterial manufacturing capacity. Based on the increased demand for larger volume manufacturing, List Labs recently added single-use equipment including a Sartorius 500L Stedim bioreactor and a Cytiva ÄKTA Readyflux XL tangential flow filtration system to their California GMP drug manufacturing facility. The expansion, available now to customers, will signif...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters